So other company's have achieved acute lymphoblastic leukemia approval and TLON remains unable to obtain a partner...Hmmm...seems like TLON is dead in the water. Why is it that 4 months after approval TLON is unable to find a partner? All the shareholders get is an allusion that there is a deal coming. I am calling #$%$. at this point. TLON please prove me wrong.
1Q 2013, it start on Jan 1st 2013 and ends on March 31, 2013. They promised a deal by then. TLON made a deal with the Devil (WP) by selling shares for .35 and we common shareholders are paying the price for it. With 160 million fully diluted shares, a $2.00/Share would put the TLON market cap to be 320 million. I personally think TLON is at least worth that much and that is the reason I did not sell my shares yet. But when you are dealing with the Devil, there is no telling.
stplaids, as we "veterans" here know, their is much value (potential, obviously) in the co. I think the co's and WP overall strategy and expectations are on schedule. We are in the dark and therefore feel the uncertainty, but we are a hell of a lot further along, having made it over the first and biggest hurdle months ago. The menadione study at Mayo's should be a big shot in the arm for the co's future value and pps.